Search

Gerresheimer AG

Open

BrancheGesundheitswesen

54.6 -18.08

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

54

Max

66.45

Schlüsselkennzahlen

By Trading Economics

Einkommen

11M

38M

Verkäufe

70M

569M

KGV

Branchendurchschnitt

22.028

63.778

EPS

1.63

Dividendenrendite

1.71

Gewinnspanne

6.731

Angestellte

12,142

EBITDA

16M

117M

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+49.44% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

1.71%

2.39%

Nächstes Ergebnis

11. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-382M

2.4B

Vorheriger Eröffnungskurs

72.68

Vorheriger Schlusskurs

54.6

Nachrichtenstimmung

By Acuity

27%

73%

63 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Bearish Evidence

Gerresheimer AG Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

13. Mai 2024, 11:16 UTC

Top News

German Companies Bet on AI But Payoff Could Be Years Away -- Talking Markets

Gerresheimer AG Prognose

Kursziel

By TipRanks

49.44% Vorteil

12-Monats-Prognose

Durchschnitt 101.47 EUR  49.44%

Hoch 122.5 EUR

Tief 85.1 EUR

Basierend auf 13 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Gerresheimer AG – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

13 ratings

12

Buy

1

Halten

0

Sell

Technischer Score

By Trading Central

N/A / 74.9Unterstützung & Widerstand

Kurzfristig

Bearish Evidence

Mittelfristig

Bearish Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

63 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.